Sort
130,381 grants matching “hiv”
Vanderbilt HIV Clinical Trials Unit (CTU)
$2,679,601David W Haas · Vanderbilt University Medical Center · UM1 · FY2022 · AI
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
$2,678,430David J Moore · Scripps Institution Of Oceanography · N01 · FY2025 · MH
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$2,678,044James M Vergeront · Wisconsin Department Of Health Services · U62 · FY2012 · PS
Drug at the Right Place & Concentration: Optimizing Combination Vaginal Ring Pr*
$2,677,669Betsy C. Herold · Albert Einstein College Of Medicine · U19 · FY2013 · AI
Developmental Core
$2,677,325Paul A Volberding · University Of California, San Francisco · P30 · FY2013 · AI
High Resolution Analysis of Env-directed B Cells to Accelerate Vaccine Design
$2,676,775Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2018 · AI
Immune Responses to Malaria and HIV Infection and Immunization
$2,675,440Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2018 · AI
Monitoring the Future: A Cohort-Sequential Panel Study of Drug Use, Ages 19-65
$2,675,194Megan Elizabeth Patrick · University Of Michigan At Ann Arbor · R01 · FY2024 · DA
UCLA Center for AIDS Research (CFAR)
$2,675,166Jerome A. Zack · University Of California Los Angeles · P30 · FY2010 · AI
Preventive Vaccines for HIV
$2,673,929Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
PS09-904, TECHNICAL ASSISTANCE TO ETHIOPIA IN SUPPORT OF HIV PREVENTION AND CARE AND TREATM
$2,673,000Wuleta Lemma · Tulane University Of Louisiana · U2G · FY2011 · PS
Prevalence, risk factors and consequences of complex M. Tuberculosis infections
$2,672,711Theodore H Cohen · Brigham And Women'S Hospital · DP2 · FY2010 · OD
CRC: Connecting Biology with Chemistry through Multiscale Theory and Computer Simulation
$2,672,000Gregory A Voth · University Of Utah · · FY2006 · MPS
DNA/MWA Immunogens, Cross-clade Immune Responses
$2,670,866Emory University · P01 · FY2004 · AI
Center/Coordination, Analysis and Management/MACS
$2,670,224Lisa P Jacobson · Johns Hopkins University · UM1 · FY2015 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$2,669,207Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2008 · AI
Computational Biology in Systems Immunology and Infectious Disease Modeling
$2,667,952Martin Meier-Schellersheim · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations
$2,667,277Sandra Ann Springer · Yale University · U01 · FY2023 · DA
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$2,667,211Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA
Development of a Vaccine for HIVAIDS: Humoral Immunity
$2,666,567Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Monitoring the Future: A Cohort-Sequential Panel Study of Drug Use, Ages 19-65
$2,666,307Megan Elizabeth Patrick · University Of Michigan At Ann Arbor · R01 · FY2025 · DA
Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development
$2,666,257Shaunna Shen · Duke University · N01 · FY2022 · AI
Northwestern University Clinical Trial Unit
$2,665,678Robert L. Murphy · Northwestern University At Chicago · UM1 · FY2013 · AI
Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations
$2,665,428Sandra Ann Springer · Yale University · U01 · FY2021 · DA
University of North Carolina Global HIV Prevention and Treatment Clinical Trials
$2,665,274Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2015 · AI